| 英文别名： |
(2S,3S,4R,5R)-5-(2-Chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide;2-Cl-IB-MECA;(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide;2-Chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide;b-D-Ribofuranuronamide,1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-me...;b-D-Ribofuranuronamide,1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-;CF-102;Chloro-IB-MECA;2-chloro-IB-MECA;CF102;CI-IB-MECA;Cl-IB-MECA;2-Chloro-N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide;Netazepide;2-Cl-IB-MECA (CF-102);Cl-IB-MECA, 2-Chloro-N6-(3-iodobenzyl)-adenosine-5μ-N-methyluronamide;1-[2-Chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-β-D-ribofuranuronamide;1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-b-D-ribofuranuronamide;Namodenoson;C-Ibza-MU;2Cl-IB-MECA;1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE;Z07JR07J6C;2-Chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide;(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methy;1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BET;2-CL-IB-MECA;b-D-RibofuranuronaMide,1-[2-chloro-6-[[(3-iodophenyl)Methyl]aMino]-9H-purin-9-yl]-1-deoxy-N-Methyl-;GTPL457;MLS002153535;SMR001230862;P10208;1-[2-Chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-beta-D-ribofuranuronamide;2-Chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide;2-Cl-IB-MECA;2-Cl-IB-MECA;2-Chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide;NAMODENOSON [INN];J-009992;(2S,3S,4R,5R)-5-(6-(3-iodobenzylamino)-2-chloro-9H-purin-9-yl)-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide;CF-102(2-Cl-IB-MECA);DB12885;beta-D-Ribofuranuronamide, 1-(2-chloro-6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-1-deoxy-N-methyl-;NCGC00025001-02;HY-12365;Chloro-IB-MECA, solid, >=98% (HPLC);HMS2235L10;AKOS022181265;NS00069749;BDBM21221;NAMODENOSON [WHO-DD];SCHEMBL1170028;D11128;CS-5932;Namodenoson (CF-102);1-(2-Chloro-6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-1-deoxy-N-methyl-beta-D-Ribofuranuronamide;2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide;CF-102;2-Cl-IB-MECA;163042-96-4;CHEMBL431733;AC-27390;A848899;Q27076097;2-Cl-IB-Meca;DTXSID80167504;.BETA.-D-RIBOFURANURONAMIDE, 1-(2-CHLORO-6-(((3-IODOPHENYL)METHYL)AMINO)-9H-PURIN-9-YL)-1-DEOXY-N-METHYL-;CF 102;1-[2-Chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-?-D-ribofuranuronamide;HMS3412I05;DS-16397;MFCD01861178;AM84557;C3601;S0498;EX-A2882;1-(2-CHLORO-6-(((3-IODOPHENYL)METHYL)AMINO)-9H-PURIN-9-YL)-1-DEOXY-N-METHYL-.BETA.-D-RIBOFURANURONAMIDE;UNII-Z07JR07J6C;C1-IB-MECA;Namodenoson (USAN/INN);2-chloro-N6-(3-iodobenzyl)adenosine-5-N-me... |
沪公网安备31011402010658号 
